Special Issue "Nanomaterials for Imaging, Diagnosis or Therapy"

A special issue of Nanomaterials (ISSN 2079-4991).

Deadline for manuscript submissions: 30 June 2018

Special Issue Editors

Guest Editor
Prof. Dr. Ping-Shan Lai

Department of Chemistry, Ph.D. Program in Tissue Engineering and Regenerative Medicine, Research Center for Sustainable Energy and Nanotechnology, National Chung Hsing University, Taiwan
Website | E-Mail
Interests: biomaterials; drug delivery; nanomedicine; cancer therapy; smart materials
Guest Editor
Prof. Dr. Akihiro Kishimura

Department of Applied Chemistry, Kyushu University, Fukuoka, Japan
Website | E-Mail
Interests: materials chemistry; nanobiotechnology; biomaterials; nanofabrication; polymer chemistry; supramolecular chemistry
Guest Editor
Prof. Dr. Mu-Ping Nieh

Institute of Materials Science, University of Connecticut, CT, USA
Website | E-Mail
Interests: bicellar nanodiscs; nanovesicles; bilayered ribbons; nanocarriers; strung lipid-based nanoparticles; high-sensitivity biosensing

Special Issue Information

Dear Colleagues,

We are launching a Special Issue in Nanomaterials (IF: 3.553) entitled “Nanomaterials for Imaging, Diagnosis or Therapy”. The utilization of nanomaterials in technologies for biomedical applications continues to represent an important area of academic and commercial research. There are numerous strategies by which the integration of nanomaterials can improve therapeutic or diagnostic/imaging performance. In addition, the advanced fundamental understanding of interactions among biological molecules, immune response and nanomaterials is critical for the development of future medicine. Thus, this special issue aims to cover a broad range of subjects from nanomaterials synthesis to the design and characterization of biomaterials for drug delivery, imaging/diagnosis or therapy of diseases. Development of novel biotechnologies or strategies with high safety against cancer will be given priority. The format of welcomed articles includes full papers, communications and reviews. Potential topics include, but are not limited to:

  1. Nanomaterials synthesis and development for drug delivery.
  2. Synthesis and development of nanomaterials for cancer theranostics
  3. Nanochips, nanofluidics and nanofabrication for diagnosis or disease screening.
  4. Design and preparation of hybrid biomaterials or nanocomposites for drug implant.
  5. Contrast agents and biomedical imaging technologies for diagnosis.
  6. Drug conjugation or immobilization technologies for bioconjugates development.
  7. In vivo monitoring of nanocarriers and drug release/accumulation profile in target site.
  8. Effects of particles size, morphology and surface properties on biodistribution.
  9. Nanomaterials for regenerative medicine
  10. Development of nanomaterials for bioanalysis.

Prof. Dr. Ping-Shan Lai
Prof. Dr. Akihiro Kishimura
Prof. Dr. Mu-Ping Nieh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Nanocarrier
  • Drug delivery
  • Controlled release
  • Bioconjugation
  • Contrast agents
  • Biomedical imaging
  • Biosensing and bioanalysis
  • Theranostics
  • Regenerative medicine
  • Biomaterials

Published Papers (1 paper)

View options order results:
result details:
Displaying articles 1-1
Export citation of selected articles as:

Research

Open AccessArticle Evaluation of the Ability of Nanostructured PEI-Coated Iron Oxide Nanoparticles to Incorporate Cisplatin during Synthesis
Nanomaterials 2017, 7(10), 314; doi:10.3390/nano7100314
Received: 25 August 2017 / Revised: 26 September 2017 / Accepted: 5 October 2017 / Published: 12 October 2017
PDF Full-text (6553 KB) | HTML Full-text | XML Full-text | Supplementary Files
Abstract
Nanoparticles (NPs) have a high potential for biological applications as they can be used as carriers for the controlled release of bioactive factors. Here we focused on poly(ethylenimine) (PEI)-coated iron oxide hybrid NPs obtained by hydrothermal synthesis in high pressure conditions and evaluated
[...] Read more.
Nanoparticles (NPs) have a high potential for biological applications as they can be used as carriers for the controlled release of bioactive factors. Here we focused on poly(ethylenimine) (PEI)-coated iron oxide hybrid NPs obtained by hydrothermal synthesis in high pressure conditions and evaluated their behavior in culture medium in the presence or absence of cells, as well as their ability to incorporate antitumor drug cisplatin. Our results showed that the hydrothermal conditions used for Fe-PEI NPs synthesis allowed the incorporation of cisplatin, which even increased its anti-tumor effects. Furthermore, the commonly occurring phenomenon of NPs aggregation in culture medium was exploited for further entrapment of other active molecules, such as the fluorescent dye DiI and valinomycin. The molecules bound to NPs during synthesis or during aggregation process were delivered inside various cells after in vitro and in vivo direct contact between cells and NPs and their biological activity was preserved, thus supporting the therapeutic value of Fe-PEI NPs as drug delivery tools. Full article
(This article belongs to the Special Issue Nanomaterials for Imaging, Diagnosis or Therapy)
Figures

Journal Contact

MDPI AG
Nanomaterials Editorial Office
St. Alban-Anlage 66, 4052 Basel, Switzerland
E-Mail: 
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
Editorial Board
Contact Details Submit to Special Issue Edit a special issue Review for Nanomaterials
logo
loading...
Back to Top